Agman Capital LLC bought a new position in shares of Avantor, Inc. (NYSE:AVTR – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 341,605 shares of the company’s stock, valued at approximately $3,915,000. Avantor comprises 3.3% of Agman Capital LLC’s holdings, making the stock its 13th largest holding.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Royal Bank of Canada boosted its holdings in shares of Avantor by 104.3% during the first quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock valued at $3,302,000 after acquiring an additional 104,022 shares during the period. Empowered Funds LLC boosted its holdings in shares of Avantor by 40.3% during the first quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock valued at $286,000 after acquiring an additional 5,075 shares during the period. Cetera Investment Advisers boosted its holdings in shares of Avantor by 40.2% during the second quarter. Cetera Investment Advisers now owns 40,289 shares of the company’s stock valued at $542,000 after acquiring an additional 11,543 shares during the period. Quantbot Technologies LP acquired a new position in shares of Avantor during the second quarter valued at $232,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of Avantor by 214.9% during the second quarter. Arrowstreet Capital Limited Partnership now owns 124,076 shares of the company’s stock valued at $1,670,000 after acquiring an additional 84,679 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.
Insider Buying and Selling at Avantor
In other news, Director Simon Dingemans purchased 25,000 shares of the stock in a transaction dated Friday, May 1st. The shares were bought at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the transaction, the director owned 25,000 shares in the company, valued at $203,500. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Gregory T. Lucier purchased 10,000 shares of the stock in a transaction dated Friday, May 8th. The shares were purchased at an average price of $8.32 per share, for a total transaction of $83,200.00. Following the completion of the transaction, the director owned 60,000 shares in the company, valued at $499,200. This trade represents a 20.00% increase in their position. The SEC filing for this purchase provides additional information. 0.28% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Read Our Latest Stock Analysis on Avantor
Avantor Stock Down 3.0%
Shares of Avantor stock opened at $9.38 on Friday. The business’s fifty day moving average price is $8.38 and its two-hundred day moving average price is $9.63. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. The company has a market capitalization of $6.40 billion, a P/E ratio of -11.57, a PEG ratio of 5.45 and a beta of 0.97. Avantor, Inc. has a 1-year low of $7.26 and a 1-year high of $15.93.
Avantor (NYSE:AVTR – Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter in the previous year, the business earned $0.23 EPS. The firm’s revenue for the quarter was up .0% on a year-over-year basis. As a group, research analysts forecast that Avantor, Inc. will post 0.79 EPS for the current year.
Avantor Company Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Recommended Stories
- Five stocks we like better than Avantor
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
